ImageneBio, Inc. (IMA) support and resistance · rev $9.2M
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
This page maps ImageneBio, Inc. (IMA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
IMA currently screens at market cap $64.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IMA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IMA quote page for the session range and the stock page for the full model.
Not investment advice.